Profound Medical: Montel Williams to Headline Webinar on Nov 5

Profound Medical Corp. announced that Emmy Award-winning broadcaster and U.S. Navy veteran Montel Williams will headline the next “Let’s Huddle” virtual webinar for prostate health patients on November 5, 2026, at 3 p.m.

Montel Williams Joins November 5 Let’s Huddle Patient Webinar

The online event centers on a conversation between Williams and webinar host Leonard Wheeler, a former National Football League player, prostate cancer survivor, and global patient ambassador for Profound Medical. Williams will discuss health advocacy, personal resilience, making informed medical decisions, and preserving quality of life. Registration for the session is open through the community platform at www.letshuddle.org, with a recorded replay scheduled for publication on the site following the broadcast.

Prostate Community Program Led by Leonard Wheeler

The "Let's Huddle" initiative functions as an international support network designed to help men and their families make prostate treatment decisions through education and peer connection. Wheeler, who played eight years in the NFL and serves as co-director of NFL Legends, leads the community outreach efforts. Tom Tamberrino, chief commercial officer at Profound Medical, stated that the program was built to give men and their families a safe space to ask difficult questions and share personal experiences, adding that Williams’ participation reinforces the company’s commitment to prioritizing patients.

Tulsa-PRO System Expansion in Veterans Affairs Facilities

Alongside the patient community outreach, Profound Medical highlighted recent progress in expanding access to its technology within government healthcare facilities. Arun Menawat, representative at Profound Medical, noted that men facing prostate disease deserve clear information, meaningful support, and treatment options that protect their quality of life. The Tulsa procedure uses magnetic resonance imaging guidance to deliver incision-free prostate tissue ablation designed for precision and personalized care.

Profound Medical Projects Revenue Growth Through 2028

According to securities consensus estimates cited by Choicestock, Profound Medical projects total revenue to reach $26.32 million in 2026, marking a 123.98% increase over the previous year. Projected revenues climb further to $42.29 million in 2027 and $60.87 million by 2028. Earnings per share estimates show narrowing net losses, moving from minus $0.84 in 2026 to minus $0.59 in 2027 and minus $0.07 by 2028, alongside an estimated return on equity of minus 247.22% for 2026.